[1]袁也晴,张学齐,汪青蓉,等.KIF14在前列腺癌细胞中的表达及作用[J].医学信息,2019,32(09):68-70.[doi:10.3969/j.issn.1006-1959.2019.09.022]
　YUAN Ye-qing,ZHANG Xue-qi,WANG Qing-rong,et al.Expression and Role of KIF14 in Prostate Cancer Cells[J].Journal of Medical Information,2019,32(09):68-70.[doi:10.3969/j.issn.1006-1959.2019.09.022]
点击复制

KIF14在前列腺癌细胞中的表达及作用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年09期
页码:
68-70
栏目:
论著
出版日期:
2019-05-01

文章信息/Info

Title:
Expression and Role of KIF14 in Prostate Cancer Cells
文章编号:
1006-1959（2019）09-0068-03
作者:
袁也晴; 张学齐; 汪青蓉; 张轶庠
（深圳市人民医院泌尿外科，广东 深圳 518020）
Author(s):
YUAN Ye-qing; ZHANG Xue-qi; WANG Qing-rong; ZHANG Yi-xiang
(Department of Urology,Shenzhen People's Hospital,Shenzhen 518020,Guangdong,China)
关键词:
驱动蛋白家族成员14; 前列腺癌; 癌基因; 增殖
Keywords:
Kinesin family member 14; Prostate cancer; Oncogene; Proliferation
分类号:
R737.25
DOI:
10.3969/j.issn.1006-1959.2019.09.022
文献标志码:
A
摘要:
目的 研究驱动蛋白家族成员14（KIF14）在前列腺癌（PCa）细胞中的表达和对PCa细胞的生物学功能的影响。方法 采用RT-PCR检测KIF14在PCa细胞系中的RNA表达情况。使用siRNA（siKIF14组或siControl组）分别敲减PCa癌细胞22Rv1，RT-PCR验证敲减效率后，采用细胞计数、Transwell试验分别检测对两侧细胞增殖、迁移的影响。结果 KIF14在多种PCa细胞系中过表达；siKIF14组22Rv1细胞的 KIF14的mRNA水平相比siControl组降低，表达量下降达（88±2）%，差异有统计学意义（P＜0.05）；在KIF14表达被敲减后，siKIF14组细胞增殖相比siControl组在24 h和48 h均降低，差异有统计学意义（P＜0.05）；Transwell小室试验检测结果显示，24h后，siKIF14组细胞迁移数（139.33±28.74）/每视野，较siControl组的（436.00±51.56）/每视野减少，差异有统计学意义（P＜0.05）。结论 KIF14是潜在的癌基因，敲减KIF14表达可抑制PCa细胞的增殖与迁移，可能在PCa进展中发挥作用。
Abstract:
Objective To study the expression of kinesin family member 14 (KIF14) in prostate cancer (PCa) cells and its effect on the biological function of PCa cells. Methods The expression of KIF14 in PCa cell line was detected by RT-PCR. PCR cancer cells 22Rv1 were knocked down by siRNA (siKIF14 group or siControl group), and the knockdown efficiency was verified by RT-PCR. The effects of cell proliferation and migration were detected by cell counting and Transwell assay, respectively. Results KIF14 was overexpressed in various PCa cell lines. The mRNA level of KIF14 in 22Rv1 cells of siKIF14 group was lower than that in siControl group, and the expression level decreased (88±2)%, the difference was statistically significant (P<0.05). After KIF14 expression was knocked down, the cell proliferation of siKIF14 group was lower than that of siControl group at 24 h and 48 h,the difference was statistically significant (P<0.05). The results of Transwell chamber test showed that after 24 h, the number of cell migration in the siKIF14 group (139.33±28.74)/per visual field was lower than that in the siControl group (436.00±51.56)/per visual field,the difference was statistically significant (P<0.05). Conclusion KIF14 is a potential oncogene. Knockdown of KIF14 expression can inhibit the proliferation and migration of PCa cells, which may play a role in the progression of PCa.

参考文献/References:

[1]Siegel RL,Miller KD,Jemal A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34.
[2]Westdorp H,Skold AE,Snijer BA,et al.Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigens[J].Front Immunol,2014(5):191.
[3]Miki H,Okada Y,Hirokawa N.Analysis of the kinesin superfamily:insights into structure and function[J].Trends Cell Biol,2005,15(9):467-476.
[4]She ZY,Yang WX.Molecular mechanisms of kinesin-14 motors in spindle assembly and chromosome segregation[J].J Cell Sci,2017,130(13):2097-2110.
[5]Gruneberg U,Neef R,Li X,et al.KIF14 and citron kinase act together to promote efficient cytokinesis[J].J Cell Biol,2006,172(3):363-372.
[6]Xu H,Choe C,Shin SH,et al.Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma[J]. Exp Mol Med,2014(46):e97.
[7]Yang T,Zhang XB,Zheng ZM.Suppression of KIF14 expression inhibits hepatocellular carcinoma progression and predicts favorable outcome[J].Cancer Sci,2013,104(5):552-557.
[8]Yang Z,Li C,Yan C,et al.KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer[J].Biochim Biophys Acta Mol Basis Dis,2019,1865(1):181-192.
[9]Singel SM,Cornelius C,Zaganjor E,et al.KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triplenegativebreast cancer[J].Neoplasia,2014,16(3):247-256.
[10]Wang Q,Wang L,Li D,et al.Kinesin family member 14 is a candidate prognosticmarker for outcome of glioma patients[J].Cancer Epidemiol,2013,37(1):79-84.
[11]Wang ZZ,Yang J,Jiang BH,et al.KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer[J].Int J Oncol,2018,53(5):1939-1952.
[12]Theriault BL,Pajovic S,Bernardini MQ,et al.Kinesin family member 14:an independent prognostic marker and potential therapeutic target for ovarian cancer[J].Int J Cancer,2012,130(8):1844-1854.
[13]Theriault BL,Corson TW.KIF14:a clinically relevant kinesin and potential target for cancer therapy[M].Kinesins and Cancer,2015:149-170.
[14]Svec D,Tichopad A,Novosadova V,et al.How good is a PCR efficiency estimate:Recommendations for precise and robust qPCR efficiency assessments[J].BiomolDetect Quantif,2015(3):9-16.
[15]Xiao Y,Yuan Y,Zhang Y,et al.CMTM5 is reduced in prostate cancer andinhibits cancer cell growth in vitro and in vivo[J].Clin Transl Oncol,2015,17(6):431-437.
[16]Rhodes DR,Yu J,Shanker K,et al.ONCOMINE:a cancer microarray database and integrateddata-mining platform[J].Neoplasia,2004,6(1):1-6.
[17]Varambally S,Yu J,Laxman B,et al.Integrativegenomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression[J].Cancer Cell,2005,8(5):393-406.
[18]Yu YP,Landsittel D,Jing L,et al.Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy[J].J Clin Oncol,2004,22(14):2790-2799.

相似文献/References:

[1]廖 祺,黄 一,徐 雪.前列腺癌骨转移的疼痛管理[J].医学信息,2018,31(06):51.[doi:10.3969/j.issn.1006-1959.2018.06.017]
　LIAO Qi,HUANG Yi,XU Xue.Pain Management of Bone Metastasis in Prostate Cancer[J].Journal of Medical Information,2018,31(09):51.[doi:10.3969/j.issn.1006-1959.2018.06.017]
[2]袁长翮.超声引导下经直肠前列腺穿刺诊断前列腺癌的价值研究[J].医学信息,2018,31(04):156.[doi:10.3969/j.issn.1006-1959.2018.04.058]
　YUAN Chang-he.The Value of Ultrasound Guided Transrectal Prostate Puncture in the Diagnosis of Prostate Cancer[J].Journal of Medical Information,2018,31(09):156.[doi:10.3969/j.issn.1006-1959.2018.04.058]
[3]胡春燕,吴天天,王 殊,等.前列腺癌患者自我感受负担及其影响因素研究[J].医学信息,2018,31(13):173.[doi:10.3969/j.issn.1006-1959.2018.13.054]
　HU Chun-yan,WU Tian-tian,WANG Shu,et al.Study on Self-perceived Burden and its Influencing Factors in Patients with Prostate Cancer[J].Journal of Medical Information,2018,31(09):173.[doi:10.3969/j.issn.1006-1959.2018.13.054]
[4]曹志彬,王元天,杨伟忠,等.前列腺健康指数在前列腺癌早期诊断中的价值[J].医学信息,2018,31(23):29.[doi:10.3969/j.issn.1006-1959.2018.23.009]
　CAO Zhi-bin,WANG Yuan-tian,YANG Wei-zhong,et al.The Value of Prostate Health Index in Early Diagnosis of Prostate Cancer[J].Journal of Medical Information,2018,31(09):29.[doi:10.3969/j.issn.1006-1959.2018.23.009]
[5]张 莹,谢 静.前列腺癌预后标志的研究[J].医学信息,2019,32(09):7.[doi:10.3969/j.issn.1006-1959.2019.09.003]
　ZHANG Ying,XIE Jing.Prognostic Markers of Prostate Cancer[J].Journal of Medical Information,2019,32(09):7.[doi:10.3969/j.issn.1006-1959.2019.09.003]
[6]胡嘉莉,华 琳.miRNA-mRNA双重表达谱在前列腺癌分子调控机制中的作用[J].医学信息,2022,35(16):18.[doi:10.3969/j.issn.1006-1959.2022.16.004]
　HU Jia-li,HUA Lin.Role of miRNA-mRNA Dual Expression Profile in Molecular Regulation of Prostate Cancer[J].Journal of Medical Information,2022,35(09):18.[doi:10.3969/j.issn.1006-1959.2022.16.004]
[7]王 乾,孙 宾,李殷南,等.尿液中肌氨酸、PCA3mRNA在前列腺癌 早期诊断中的应用[J].医学信息,2019,32(14):175.[doi:10.3969/j.issn.1006-1959.2019.14.059]
　WANG Qian,SUN Bin,LI Yin-nan,et al.Application of Urinary Sarcosine and PCA3mRNA in Early Diagnosis of Prostate Cancer[J].Journal of Medical Information,2019,32(09):175.[doi:10.3969/j.issn.1006-1959.2019.14.059]
[8]李熹阳,谷明宇,华 琳.影响前列腺癌风险的关键基因识别[J].医学信息,2020,33(02):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
　LI Xi-yang,GU Ming-yu,HUA Lin.Identification of Key Genes Affecting Prostate Cancer Risk[J].Journal of Medical Information,2020,33(09):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
[9]黄 鹏,廖鑫鑫,陆文宝,等.临床评分系统预测前列腺癌根治术后生化复发的研究[J].医学信息,2020,33(08):76.[doi:10.3969/j.issn.1006-1959.2020.08.025]
　HUANG Peng,LIAO Xin-xin,LU Wen-bao,et al.Clinical Scoring System Predicts the Value of Biochemical Recurrence after Radical Prostatectomy[J].Journal of Medical Information,2020,33(09):76.[doi:10.3969/j.issn.1006-1959.2020.08.025]
[10]陈彦君,刘建萍,龚志勇.预测前列腺癌根治术后生化复发的研究[J].医学信息,2021,34(05):49.[doi:10.3969/j.issn.1006-1959.2021.05.015]
　CHEN Yan-jun,LIU Jian-ping,GONG Zhi-yong.Study on the Prediction of Biochemical Recurrence After Radical Prostatectomy[J].Journal of Medical Information,2021,34(09):49.[doi:10.3969/j.issn.1006-1959.2021.05.015]

更新日期/Last Update: 2019-05-01